• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Updates, 08-08-2026: General Updates

    08-08-2026 | 11:38 am

    AstraZeneca Pharma India secured approval to market Enhertu for an additional HER2-positive breast cancer indication. This expands the drug's potential market in India, signaling future revenue growth opportunities.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited